Bronchopulmonary dysplasia
Drug research and approvals for bronchopulmonary dysplasia: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 47 studies of bronchopulmonary dysplasia are recruiting on ClinicalTrials.gov, Health Canada has authorized 6 drug trials for it since 2013, and FDA has 1 approved and 18 open orphan designations naming it.
- Recruiting worldwide: 47
- Trials authorized in Canada: 6
- FDA orphan approvals: 1
- EU medicines: 0
Recruiting Now
Newest start dates first, of 47 recruiting on ClinicalTrials.gov ↗- Continued Pressure for Alveolar Protection (CPAP Trial)NCT07417111 · Not applicable · NICHD Neonatal Research Network · starts Nov 5, 2026
- Ventilator Pressure and Optimization of Compliance and HemodynamicsNCT06512935 · Not applicable · University of Alabama at Birmingham · starts Oct 1, 2026
- Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsNCT06373289 · Not applicable · University of Alabama at Birmingham · starts Sep 22, 2026
- High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm InfantsNCT07307612 · Phase 1 / Phase 2 · University of Alabama at Birmingham · starts Sep 21, 2026
- Impact of Higher Zinc Supplementation on Neonatal Weight VelocityNCT07896070 · Phase 4 · Augusta University · starts Aug 1, 2026
- Pharmacokinetics and Placental Transfer of CaffeineNCT07570121 · Phase 1 · Indiana University · starts Jun 1, 2026
- Lipid Infusions to Optimize Nutrition TrialNCT06915441 · Phase 2 · The University of Texas Health Science Center, Houston · starts Apr 29, 2026
- Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowNCT07561125 · Phase 2 · International Peace Maternity and Child Health Hospital · starts Apr 23, 2026
- Respiratory Exacerbations in Children With Bronchopulmonary Dysplasia (BPD): A Case-Control StudyNCT07666438 · Not reported · IRCCS Azienda Ospedaliero-Universitaria di Bologna · starts Apr 17, 2026
- PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary…NCT07101640 · Phase 1 / Phase 2 · Duke University · starts Feb 23, 2026
Trials Authorized in Canada
Newest first; search them all in Canada trials| Dec 6, 2019 | Helping underdeveloped lungs with cells (hulc): mesenchymal stromal cells in extreme preterm infants at risk of developing bronchopulmonary dysplasia - phase 1…ALLOGENEIC UMBILICAL CORD TISSUE-DERIVED MESENCHYMAL STROMAL CELLS | OTTAWA HOSPITAL RESEARCH INSTITUTE | Ongoing |
| May 16, 2019 | Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasiaSILDENAFIL | UNIVERSITY OF NORTH CAROLINA | Closed |
| Nov 1, 2018 | Multi-centre randomized controlled trial of surfactant plus budesonide to improve survival free of bronchopulmonary dysplasia in extremely preterm infantsBUDESONIDE | MURDOCH CHILDREN'S RESEARCH INSTITUTE | Closed |
| Aug 1, 2018 | Pharmacokinetics and pharmacodynamics of budesonide with intratracheal surfactant (bits) administration in preterm infants < 29 weeks gestational ageBUDESONIDE/ BLES (BOVINE LIPID EXTRACT SURFACTANT) | UNIVERSITY OF MANITOBA | Pending |
| Jun 21, 2017 | Evaluation of safety and thrombolytic effect of ascending doses of ds9231(ts23) in subjects with intermediate-risk (sub-massive) acute pulmonary embolism (pe)DS9231 | Daiichi Sankyo | Pending |
| Jul 5, 2013 | The evaluation of the effectiveness of inhaled budesonide for non-ventilated infants at high risk of bronchopulmonary dysplasia: the i-bud pilot studyBUDESONIDE | SUNNYBROOK RESEARCH INSTITUTE | Pending |
FDA Orphan Designations
Approved first, then open designations, newest first; 15 of 19| Jan 18, 1996 | RespigamFor the prevention of serious lower respiratory tract infections caused by RSV in children less than 24 months of age with bronchopulmonary… | MedImmune & Massachussetts Public Health Biologics Labs. | Approved |
| Oct 25, 2022 | Human allogeneic umbilical cord mesenchymal stromal…Prevention of bronchopulmonary dysplasia | Exo Biologics SA | Designated |
| Aug 5, 2022 | Allogeneic umbilical cord-derived mesenchymal stem cell drugPrevention of Bronchopulmonary Dysplasia | Meribank Biotech Co. Ltd. | Designated |
| Jun 6, 2022 | azithromycinPrevention of bronchopulmonary dysplasia in neonates. | Iorek Pharma Limited | Designated |
| Jul 7, 2021 | mecasermin rinfabatePrevention of bronchopulmonary dysplasia | OHB Neonatology Ltd | Designated |
| Feb 8, 2021 | Mesenchymal Stem Cell-derived Extracellular VesiclesPrevention of Bronchopulmonary Dysplasia in neonates | Stella Kourembanas, M.D. | Designated |
| Jan 18, 2021 | N-((2S,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-nit…Prevention of bronchopulmonary dysplasia | AyuVis Research, Inc. | Designated |
| Nov 1, 2017 | recombinant fragment human surfactant protein-DPrevention of bronchopulmonary dysplasia | Trimunocor Ltd. | Designated |
| Aug 8, 2016 | Retinol palmitatePrevention of bronchopulmonary dysplasia. | Orphanix GmbH | Designated |
| Jul 14, 2015 | vitamin A palmitatePrevention of bronchopulmonary dysplasia. | Advent Therapeutics, Inc. | Designated |
| Jun 23, 2014 | recombinant human surfactant protein DPrevention of bronchopulmonary dysplasia | Airway Therapeutics LLC | Designated |
| Nov 26, 2013 | human umbilical cord blood-derived mesenchymal stem cellsPrevention of bronchopulmonary dysplasia | MEDIPOST America, Inc. | Designated |
| Mar 26, 2010 | Water-miscible vitamin A palmitatePrevention of bronchopulmonary dysplasia. | Fox Pharma, Inc. | Designated |
| May 23, 2006 | LucinactantPrevention of bronchopulmonary dysplasia in premature infants | Lee’s Pharmaceutical (HK) Limited | Designated |
| Oct 21, 2005 | LucinactantTreatment of bronchopulmonary dysplasia in premature infants. | Lee’s Pharmaceutical (HK) Limited | Designated |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA